After the diagnosis: Getting follow-up care right in melanoma | 30 mins

(0 review)
30
students
0
Free

As patients transition from treatment to routine monitoring, clinicians play a crucial part in detecting recurrence early, supporting wellbeing, and guiding patients through survivorship....

Free

Neoadjuvant treatment in 2025 | 2 hr 8 min

(0 review)
144
students
0
Free

Following recent PBS listings of neoadjuvant regimens for Stage III melanoma in Australia, there is an urgent need for practical, real-world guidance on how...

Free

Overdiagnosis or early detection? The controversy of melanoma in situ | 40 min

(1 review)
686
students
1
Free

As melanoma in situ diagnoses rise, concerns about overdiagnosis are growing — with real implications for patients, clinicians and the health system. In this...

Free

Utilising melanoma risk prediction tools for newly diagnosed patients | 31 min

(1 review)
924
students
1
Free

In this episode from our podcast Melanoma Insights for Professionals, we explore how melanoma risk prediction tools are transforming clinical decision-making for newly diagnosed...

Free

Reconsidering the surgical approach in cutaneous melanoma | 11 min

(0 review)
1019
students
0
Free

In this presentation, recorded at the 57th Annual Scientific Meeting of The Australasian College of Dermatologists, Dr Mary-Ann El Sharouni challenges the routine use...

Free

Cutaneous immune and targeted therapy related adverse events | 11 min

(0 review)
1019
students
0
Free

In this presentation, recorded at the 57th Annual Scientific Meeting of The Australasian College of Dermatologists, Dr Lina Ivert discusses the management of cutaneous...

Free